Caas Capital Management LP X Biotech Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$15.83 - $17.84 $918,884 - $1.04 Million
-58,047 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$15.92 - $20.3 $1.28 Million - $1.63 Million
-80,269 Reduced 58.03%
58,047 $997,000
Q4 2020

Feb 12, 2021
BUY
$15.65 - $19.92 $2.16 Million - $2.76 Million
138,316 New
138,316 $2.17 Million

Others Institutions Holding XBIT

# of Institutions
50
Shares Held
4.87M
Call Options Held
0
Put Options Held
0
View Full List

About XBiotech Inc.

XBIT Quotes by TradingView
  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $118M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email